Pharmaceuticals and Healthcare Reports Liver Cancer Market | Page 2

The Liver Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic
development for Liver Cancer and features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities /Institutes, the molecules developed
by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and
Discovery stages are 1, 17, 76, 52, 8, 121 and 19 respectively. Similarly, the Universities portfolio
in Phase III, Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 1, 15, 8, 1, 30
and 3 molecules, respectively.
Liver Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage. The guide is built using data and information
sourced from Radiant Insights's proprietary databases, company/university websites, clinical trial
registries, conferences, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a real time basis.
Request a Sample Copy of This Report @
http://www.radiantinsights.com/research/liver-cancer-pipeline-review-h2-
2016/request-sample
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Liver Cancer
(Oncology).
- The pipeline guide reviews pipeline therapeutics for Liver Cancer (Oncology) by companies and
universities/research institutes based on information derived from company and industry-specific
sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from
pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise,
product description, descriptive licensing and collaboration details, R&D brief, MoA & other
developmental activities.
- The pipeline guide reviews key companies involved in Liver Cancer (Oncology) therapeutics and
enlists all their major and minor projects.
- The pipeline guide evaluates Liver Cancer (Oncology) therapeutics based on mechanism of action
(MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
Follow Us: